Literature DB >> 1589376

Glomerulonephritis associated with antibodies to neutrophil cytoplasm and glomerular basement membrane.

D R McCance1, A P Maxwell, C M Hill, C C Doherty.   

Abstract

The prognosis for recovery of renal function of oligoanuric patients with anti-glomerular basement membrane disease is generally regarded as poor. Five patients are reported with dialysis-dependent renal failure in whom antibodies were present simultaneously both to neutrophil cytoplasm and glomerular basement membrane all of whom responded, at least initially, to immunosuppressive therapy and plasma exchange. Two of the 5 remain in clinical and immunological remission at 25 and 51 months of follow-up. We suggest that reversal of dialysis-dependent renal failure may be possible in some patients who display this dual antibody positivity.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1589376      PMCID: PMC2399252          DOI: 10.1136/pgmj.68.797.186

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  6 in total

Review 1.  ANCA-associated renal disease.

Authors:  R J Falk
Journal:  Kidney Int       Date:  1990-11       Impact factor: 10.612

2.  Delineation of a standard procedure for indirect immunofluorescence detection of ANCA.

Authors:  A Wiik
Journal:  APMIS Suppl       Date:  1989

Review 3.  Autoimmunity in rapidly progressive glomerulonephritis.

Authors:  C D Pusey; C M Lockwood
Journal:  Kidney Int       Date:  1989-04       Impact factor: 10.612

4.  Autoantibodies to GBM and neutrophil cytoplasm in rapidly progressive glomerulonephritis.

Authors:  D R Jayne; P D Marshall; S J Jones; C M Lockwood
Journal:  Kidney Int       Date:  1990-03       Impact factor: 10.612

5.  Reversal of renal failure in nephritis associated with antibody to glomerular basement membrane.

Authors:  A P Maxwell; W E Nelson; C M Hill
Journal:  BMJ       Date:  1988-07-30

6.  Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis.

Authors:  F J van der Woude; N Rasmussen; S Lobatto; A Wiik; H Permin; L A van Es; M van der Giessen; G K van der Hem; T H The
Journal:  Lancet       Date:  1985-02-23       Impact factor: 79.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.